Published in J Clin Endocrinol Metab on July 01, 1999
¹⁸F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy. Eur J Nucl Med Mol Imaging (2012) 1.50
The value of positron emission tomography in the surgical management of recurrent papillary thyroid carcinoma. World J Surg (2008) 1.42
Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease. J Thyroid Res (2012) 1.19
New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin (2013) 1.16
Axillary lymph node metastasis in recurrence of papillary thyroid carcinoma: a case report. Wien Klin Wochenschr (2006) 1.03
Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma. Nucl Med Mol Imaging (2010) 0.98
Role and cost effectiveness of PET/CT in management of patients with cancer. Yale J Biol Med (2010) 0.97
Expression patterns of glucose transporter-1 gene and thyroid specific genes in human papillary thyroid carcinoma. Nucl Med Mol Imaging (2014) 0.91
The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Prognostication, Diagnosis, and Management of Thyroid Carcinoma. J Thyroid Res (2011) 0.90
Imaging for staging and management of thyroid cancer. Cancer Imaging (2008) 0.89
American Thyroid Association statement on preoperative imaging for thyroid cancer surgery. Thyroid (2015) 0.88
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer. Eur Radiol (2007) 0.87
Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg (2001) 0.87
Effectiveness of [(124)I]-PET/CT and [(18)F]-FDG-PET/CT for localizing recurrence in patients with differentiated thyroid carcinoma. J Korean Med Sci (2012) 0.86
The role of 18F-fluorodeoxyglucose positron emission tomography in thyroid neoplasms. Oncologist (2011) 0.85
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging (2008) 0.84
F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis. Acta Radiol (2015) 0.80
Clinical determinants of fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)iodine whole body scans after (131)iodine therapy. Malays J Med Sci (2014) 0.79
Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma. PLoS One (2015) 0.78
Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro. Eur J Nucl Med Mol Imaging (2004) 0.78
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma. Br J Radiol (2012) 0.76
Controversies in the management and followup of differentiated thyroid cancer: beyond the guidelines. J Thyroid Res (2012) 0.76
SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume. World J Surg Oncol (2015) 0.75
Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody. Nucl Med Mol Imaging (2015) 0.75
Analysis of predictability of F-18 fluorodeoxyglucose-PET/CT in the recurrence of papillary thyroid carcinoma. Cancer Med (2016) 0.75
Clinical use of PET/CT in thyroid cancer diagnosis and management. Biomed Imaging Interv J (2006) 0.75
Transoral Surgical Approach for Retropharyngeal Node Involvement in I-131-Negative 18-fluoro-2-deoxyglucose Positron Emission Tomography-Positive Recurrent Thyroid Cancer. Skull Base (2009) 0.75
Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans. J Clin Endocrinol Metab (2000) 0.75
Nuclear Medicine in Thyroid Diseases in Pediatric and Adolescent Patients. Mol Imaging Radionucl Ther (2015) 0.75
Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT. Eur Radiol (2009) 0.75
Challenging cases in thyroid cancer: a multidisciplinary approach. Eur J Nucl Med Mol Imaging (2003) 0.75
Pfam 3.1: 1313 multiple alignments and profile HMMs match the majority of proteins. Nucleic Acids Res (1999) 11.64
Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol (1969) 8.26
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol (1990) 6.62
The GDB Human Genome Data Base Anno 1992. Nucleic Acids Res (1992) 6.52
Radiometric detection of the metabolic activity of Mycobacterium tuberculosis. J Nucl Med (1975) 5.30
Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol (1983) 4.81
Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol (1991) 3.97
Mucosal hyperplasia, mucinous cystadenoma, and mucinous cystadenocarcinoma of the appendix. A re-evaluation of appendiceal "mucocele". Cancer (1973) 3.57
The GDB human genome data base anno 1993. Nucleic Acids Res (1993) 3.51
Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol (1994) 3.37
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Multilocular thymic cyst: an acquired reactive process. Study of 18 cases. Am J Surg Pathol (1991) 3.16
Automated detection of Haemophilus influenzae. Appl Microbiol (1973) 3.16
Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases. Am J Surg Pathol (1998) 3.10
Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group. Histopathology (2000) 3.05
The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature (2008) 3.02
Case 2. Desmoplastic small cell tumor with divergent differentiation. Pediatr Pathol (1989) 2.99
Neuroendocrine carcinoma within lymph nodes in the absence of a primary tumor, with special reference to Merkel cell carcinoma. Am J Surg Pathol (1992) 2.97
Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer (1997) 2.81
Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer (1996) 2.81
A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases. Am J Pathol (1986) 2.81
Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer (1979) 2.76
Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases. Cancer (1972) 2.71
Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res (1998) 2.55
Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol (1992) 2.52
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res (1989) 2.51
Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol (1980) 2.47
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index. Clin Cancer Res (1998) 2.43
Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol (1996) 2.42
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res (1981) 2.39
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol (1999) 2.38
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol (1998) 2.34
Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer (1991) 2.32
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32
Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer (1985) 2.31
Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol (1978) 2.22
Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J Natl Cancer Inst (1991) 2.19
Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer (1972) 2.16
Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities. Am J Surg Pathol (1992) 2.07
Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg (1995) 2.06
Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neurons. J Nucl Med (1989) 2.04
Imaging transgene expression with radionuclide imaging technologies. Neoplasia (2000) 2.03
Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol (1999) 2.02
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol (1989) 2.00
Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept. Hum Pathol (1991) 1.98
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol (2002) 1.96
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia. J Nucl Med (1999) 1.95
Masson's "vegetant intravascular hemangioendothelioma:" a lesion often mistaken for angiosarcoma: study of seventeen cases located in the skin and soft tissues. Cancer (1976) 1.95
The histiocytoid hemangiomas. A unifying concept embracing several previously described entities of skin, soft tissue, large vessels, bone, and heart. Hum Pathol (1979) 1.95
The case for and technique of heterotopic liver grafting. Transplant Proc (1979) 1.87
Presacral carcinoid tumors: report of three cases and review of the literature. Am J Surg Pathol (1998) 1.87
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res (2000) 1.85
Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin. Cancer (1968) 1.82
Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates. Arch Pathol Lab Med (2000) 1.74
Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys (2004) 1.74
Breast involvement by extranodal Rosai-Dorfman disease: report of seven cases. Am J Surg Pathol (1997) 1.71
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol (1995) 1.70
Quantitative imaging of iodine-124 with PET. J Nucl Med (1996) 1.69
Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol (2003) 1.68
Radioimmunotherapy with alpha-emitting nuclides. Eur J Nucl Med (1998) 1.67
Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg (1999) 1.67
Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci U S A (1995) 1.66
Hybrid PET/CT machines: optimized PET machines for the new millennium? J Nucl Med (2000) 1.65
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol (2001) 1.63
Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases. Am J Surg Pathol (1990) 1.63
Florid vascular proliferation associated with neural and neuroendocrine neoplasms. A diagnostic clue and potential pitfall. Am J Surg Pathol (1995) 1.62
Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: report of 16 cases. Am J Surg Pathol (1999) 1.60
Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid (2000) 1.59
111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology (1998) 1.59
Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab (2000) 1.59
The ophthalmologic manifestations of sinus histiocytosis with massive lymphadenopathy. Am J Ophthalmol (1979) 1.59
Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature. Am J Clin Pathol (1981) 1.59
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients. Am J Surg Pathol (1983) 1.58
Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol (1996) 1.58
p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer (1994) 1.58
Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model. Stat Med (2000) 1.57
Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis. A previously unrecognized association. Cancer (1972) 1.57
Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma". Am J Surg Pathol (1984) 1.57
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol (1998) 1.56
Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am J Pathol (1994) 1.55
Desmoid fibromatosis is a clonal process. Hum Pathol (1996) 1.54
Transcontinental consults in surgical pathology via the Internet. Hum Pathol (1997) 1.54
Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases. Am J Surg Pathol (1994) 1.54
Phase and amplitude binning for 4D-CT imaging. Phys Med Biol (2007) 1.52
Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol (2005) 1.51